2m 2m 2m 2m 2m 2m 2m
CTT Pharma Holdi (CTTH)
OTC
$0.06+$0.001 (+1.57%)
Price as of Aug 03, 2026- $3.7MMarket Cap
- 63.71%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
CTT Pharma Holdi (CTTH)
$0.06+$0.001 (+1.57%)
CTTH | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.06 | ||
Change | +$0.001 (+1.57%) | ||
Open | $0.06 | ||
High | $0.06 | ||
Low | $0.06 | ||
Previous Close | $0.06 | ||
Volume | 1,648 | ||
30-Day Average Volume | 36,960 | ||
1-Week Change | 5.74% | ||
1-Month Change | -14.00% | ||
1-Year Change | 63.71% | ||
3-Year Change | 529.58% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 58.7M | ||
Total Assets | $922,038.00 | ||
Market Cap | $3.7M | ||
Enterprise Value | $3.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$341,930.00 | ||
Free Cash Flow | -$15,527.00 | ||
EBIT | -$341,930.00 | ||
EBITDA | -$341,930.00 | ||
Net Working Capital | $738,078.00 | ||
EPS | -$0.03 | ||
Enterprise Value/EBITDA | -11 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 5 | ||
P/E | -2 | ||
PEG | N/A | ||
Price/Free Cash Flow | -240 | ||
Price/Operating Cash Flow | -240 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||